News

Counting the human cost of recession

Counting the human cost of recession

Return to profitability. It’s a phrase that businesses have been yearning for, but as more of them are starting to use it, it’s time to ask: At what cost?

Good for urinary tracts, stomachs, prostates?

Special edition: Cranberries

Science: The pick of cranberry’s health benefits

By Stephen Daniells

In the third part of our special series on cranberries, NutraIngredients looks at the science behind the reported health benefits of the little red berry.

Supply: Cranberries, from bog to cereal bar

Special edition: Cranberries

Supply: Cranberries, from bog to cereal bar

By Stephen Daniells

In the second part of our special on cranberries, NutraIngredients looks at the supply for the berry, and asks ‘what issues are bogging down cranberry supply?’

Markets: cranberry goes mainstream

Special Edition: Cranberries

Markets: cranberry goes mainstream

By Jane Byrne

In the first of a four part special edition focused on cranberries, NutraIngredients looks at the market for the berry, with its entrance into the indulgence sectors an indication perhaps that health positioning is no longer the sole driving force behind...

Eyeing European sucralose success

Eyeing European sucralose success

By Caroline Scott-Thomas

Head of JK Sucralose in Europe Leo Hokke talks to FoodNavigator.com about growth of the European sucralose market and why he thinks it is more appealing than other sweeteners for consumers and manufacturers.

Krill conflict could threaten omega-3 potential

Krill conflict could threaten omega-3 potential

The krill category and the science backing it are still emerging, but there are many who believe krill extracts have the potential to 'go big' in the healthy foods arena. Very big.

Plastic additive firms face €173m price fixing fine

Plastic additive firms face €173m price fixing fine

By Rory Harrington

Dozens of companies that produce plastic additives for food, beverage and cosmetic packaging have been fined more than €173m for their part in price fixing and market sharing cartels over a 13-year period.

Follow us

Products

View more

Webinars